Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
This randomized phase III trial studies whether weight loss in overweight and obese women may
prevent breast cancer from coming back (recurrence). Previous studies have found that women
who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk
of their breast cancer recurring, as compared to women who were thinner when their cancer was
diagnosed. This study aims to test whether overweight or obese women who take part in a
weight loss program after being diagnosed with breast cancer have a lower rate of cancer
recurrence as compared to women who do not take part in the weight loss program. This study
will help to show whether weight loss programs should be a part of breast cancer treatment.
Lebanon,Manchester,Nashua,Southwestern Vermont,St. Johnsbury, VT
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.